AR025659A1 - USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS - Google Patents

USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS

Info

Publication number
AR025659A1
AR025659A1 ARP000104818A ARP000104818A AR025659A1 AR 025659 A1 AR025659 A1 AR 025659A1 AR P000104818 A ARP000104818 A AR P000104818A AR P000104818 A ARP000104818 A AR P000104818A AR 025659 A1 AR025659 A1 AR 025659A1
Authority
AR
Argentina
Prior art keywords
modifier
combination
chemotherapeutic agent
manufacture
biorespuest
Prior art date
Application number
ARP000104818A
Other languages
Spanish (es)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR025659A1 publication Critical patent/AR025659A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Se provee uso de una combinacion de un modificador de biorespuesta y un agente quimioterapéutico para la manufactura de un medicamento para tratar tumoressolidos administrando una cantidad eficaz de una combinacion de (1) un modificador debiorespues ta y (2) un agente quimioterapéutico. También provee el uso deun modificador de biorespuesta de más de un régimen quimioterapéutico para potenciar los efectos de un régimen quimioterapéutico en un mamífero que necesita dedicho tratamientocon dicho r égimen que comprende administrar un modificador de biorespuesta además de un régimen quimioterapéutico.Use is made of a combination of a bio-response modifier and a chemotherapeutic agent for the manufacture of a medicament for treating tumor tumors by administering an effective amount of a combination of (1) a post-modifier and (2) a chemotherapeutic agent. It also provides the use of a bioresponing modifier of more than one chemotherapeutic regimen to potentiate the effects of a chemotherapeutic regimen in a mammal that needs such treatment with said regimen comprising administering a biosponder modifier in addition to a chemotherapeutic regimen.

ARP000104818A 1999-09-15 2000-09-14 USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS AR025659A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39605199A 1999-09-15 1999-09-15

Publications (1)

Publication Number Publication Date
AR025659A1 true AR025659A1 (en) 2002-12-11

Family

ID=23565645

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104818A AR025659A1 (en) 1999-09-15 2000-09-14 USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS

Country Status (8)

Country Link
EP (1) EP1214092A2 (en)
JP (1) JP2003509383A (en)
CN (1) CN1391484A (en)
AR (1) AR025659A1 (en)
AU (1) AU7373600A (en)
BR (1) BR0014001A (en)
CA (1) CA2381078A1 (en)
WO (1) WO2001019399A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60219617T2 (en) * 2001-05-16 2008-01-03 Novartis Ag COMBINATION OF N-5- 4- (4-METHYL-PIPERAZINO-METHYL) -BENZOYLAMIDO -2-METHYLPHENYL -4- (3-PYRIDIL) -2-PYRIMIDINE AMINE WITH A BIPHOSPHONATE
CN109601739B (en) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 Compound amino acid feed additive and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1059919A1 (en) * 1998-02-24 2000-12-20 Dovetail Technologies, Inc. Small molecules that increase the conversion of food to body weight gain
IL143901A0 (en) * 1998-12-23 2002-04-21 Searle & Co Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia

Also Published As

Publication number Publication date
EP1214092A2 (en) 2002-06-19
CN1391484A (en) 2003-01-15
WO2001019399A3 (en) 2001-12-13
JP2003509383A (en) 2003-03-11
BR0014001A (en) 2002-05-21
WO2001019399A2 (en) 2001-03-22
CA2381078A1 (en) 2001-03-22
AU7373600A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
BRPI0207961B8 (en) use of epothilone and capecitabine analogues to manufacture medicine to treat solid cancerous tumors and kit comprising said compounds.
BR0009213A (en) Processes and compositions for the treatment of solid tumors
ES2172654T3 (en) USE OF NSAID FOR THE TREATMENT OF SCALE CARCINOMAS OF THE ORAL OR OROPHARING CAVITY.
ES2062155T3 (en) COMPOSITIONS FOR THE TREATMENT OF NEOPLASIA CONTAINING AN ANTINEOPLASTIC AGENT AND A PROTECTIVE AGENT REDUCING SIDE EFFECTS.
AR041023A1 (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING ANTIBODY IMMUNOCATE PLAYERS FOR CD44 CYTOTOXICS AND CHEMOTHERAPEUTIC AGENTS
AR012172A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANALOGS OF LACTACISTIN AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
BR0209147A (en) Combination therapy using anti-egfr antibodies and antihormonal agents
BR0115162A (en) Effective antitumor treatments
CU23226B7 (en) ANALGESTIC COMPOSITIONS THAT INCLUDE NON-STEROID ANTI-EPILEPTIC AND ANTI-INFLAMMATORY COMPOUNDS
AR042051A1 (en) COMBINED TREATMENT AGAINST CANCER WITH AN ANTI-CANCERIGENE COMPOUND ACTIVATED BY GLUTATIONA S- TRANSFERASA (GST) AND OTHER TREATMENT AGAINST CANCER
AR023806A1 (en) USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS
ES2144119T3 (en) USE OF NON-STEROID CYCLOOXYGENASE INHIBITORS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HIGH INTRAOCULAR PRESSURE.
CA2034484A1 (en) Radioimmunotherapy using .alpha.-particles emission
BRPI0518250A2 (en) anticancer treatments
AR011133A1 (en) CONTROLLED RELEASE MICROGRANULES CONTAINING CISPLATINE, PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION AND USE IN THE MANUFACTURE OF A POLYCHIMOTHERAPY MEDICATION OR IN ASSOCIATION WITH RADIOTHERAPY.
AR012626A1 (en) A PHARMACEUTICAL COMPOSITION COMPRISING A DERIVATIVE OR ANALOGUE OF LEPTIN AS AN INHIBITOR OF THE PROLIFERATION OF TUMOR CELLS AND THE USE OF SUCH PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF MEDICINE FOR THE TREATMENT OF TUMORS
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
CR7575A (en) USE OF DOCETAXEL / DOXORRUBICIN / CYCLOPHOSPHAMIDE IN THE ADJUSING THERAPY OF CANCER OF BREAST AND OVARY
KR960700063A (en) Potentiation of temozolomide in human tumour cells
WO2003049694A3 (en) Methods of therapy for non-hodgkin's lymphoma
AR015744A1 (en) USE OF DEXMEDETOMIDINE FOR SEDATION IN INTENSIVE THERAPY
AR052830A1 (en) CLADRIBINE REGIME TO TREAT MULTIPLE SCLEROSIS
ES2188995T3 (en) USE OF AN INHIBITOR OF THE H +, K + -ATPASA IN THE TREATMENT OF NASAL POLYPS.
AR035946A1 (en) PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES
BR0110150A (en) Method and composition for treating cancer by administering apoptosis-inducing chemotherapeutic agents